心房颤动612例临床分析

Clinical Analysis of 612 Patients with Atrial Fibrillation

目的分析目前心房颤动(房颤)的病因及治疗策略,为临床医生防治此病提供参考。方法对近5年来在我科住院治疗的612例房颤患者病例资料进行回顾性分析。结果房颤患者以老年人居多,且随年龄增长而增多,65岁以上患者占79.4%。高血压及高血压性心脏病、冠心病和风湿性心脏病(风心病)为近5年来房颤的三大主要病因,其占比依次为35.6%、27.8%及13.7%。其治疗主要以"胺碘酮"控制心室率、"拜阿司匹林/华法林"抗血小板/抗凝,同时兼顾其"上游"治疗。结论高血压及高血压性心脏病、冠心病、风心病乃目前房颤的主要病因,抗凝、控制心室率为各类房颤的基本治疗策略,有效的"上游"治疗可对房颤的一级、二级预防起到一定的作用。

Objective To analyze the etiology and treatment strategy of atrial fibrillation（AF）, and to provide reference for clinicians to prevent and treat the disease. Methods The clinical data of 612 patients with atrial fibrillation in our hospital during the past 5 years were analyzed retrospectively. Results Most of the elderly patients with atrial fibrillation, and increased with age, more than 65 years old accounted for 79.4%. Hypertension and hypertensive heart disease, coronary heart disease and rheumatic heart disease（rheumatic heart disease） are the three main causes of atrial fibrillation in recent 5 years, and the proportion of them is 35.6%, 27.8% and 13.7% respectively. The main treatment is ＂amiodarone＂ to control ventricular rate, ＂aspirin/warfarin＂ antiplatelet/anticoagulant, while taking into account the ＂upstream＂ treatment. Conclusion Hypertension and hypertensive heart disease, coronary heart disease, rheumatic heart disease are the main causes of atrial fibrillation at present, anticoagulation and control basic treatment strategies for all types of ventricular rate of atrial fibrillation, the ＂upstream＂ treatment of atrial fibrillation in first grade, two grade prevention plays a certain role.